Manne, R. K., Agrawal, Y., Malonia, S. K., Banday, S., Edachery, S., Patel, A., … Santra, M. K. (2021). FBXL20 promotes breast cancer malignancy by inhibiting apoptosis through degradation of PUMA and BAX. Journal of Biological Chemistry, 297(4), 101253–101253. https://doi.org/10.1016/j.jbc.2021.101253

Manne, Rajesh Kumar, Yashika Agrawal, Sunil K. Malonia, Shahid Banday, Sarathkumar Edachery, Asha Patel, Avinash Kumar, Praveenkumar Shetty, and Manas Kumar Santra. “FBXL20 promotes breast cancer malignancy by inhibiting apoptosis through degradation of PUMA and BAX.” Journal of Biological Chemistry 297, no. 4 (October 2021): 101253–101253. https://doi.org/10.1016/j.jbc.2021.101253.

Manne RK, Agrawal Y, Malonia SK, Banday S, Edachery S, Patel A, et al. FBXL20 promotes breast cancer malignancy by inhibiting apoptosis through degradation of PUMA and BAX. Journal of Biological Chemistry. 2021 Oct;297(4):101253–101253.

Manne, Rajesh Kumar, et al. “FBXL20 promotes breast cancer malignancy by inhibiting apoptosis through degradation of PUMA and BAX.” Journal of Biological Chemistry, vol. 297, no. 4, Elsevier BV, Oct. 2021, pp. 101253–101253. Crossref, doi:10.1016/j.jbc.2021.101253.

Manne RK, Agrawal Y, Malonia SK, Banday S, Edachery S, Patel A, Kumar A, Shetty P, Santra MK. FBXL20 promotes breast cancer malignancy by inhibiting apoptosis through degradation of PUMA and BAX. Journal of Biological Chemistry. Elsevier BV; 2021 Oct;297(4):101253–101253.